Brepocitinib, CAS [[1883299-62-4]]
Artikelnummer:
BYT-ORB1296275
Produktübersicht
Artikelname:
Brepocitinib, CAS [[1883299-62-4]]
Artikelnummer:
BYT-ORB1296275
Hersteller Artikelnummer:
orb1296275
Alternativnummer:
BYT-ORB1296275-1, BYT-ORB1296275-1, BYT-ORB1296275-10, BYT-ORB1296275-100, BYT-ORB1296275-2, BYT-ORB1296275-200, BYT-ORB1296275-25, BYT-ORB1296275-5, BYT-ORB1296275-50
Hersteller:
Biorbyt
Kategorie:
Biochemikalien
Alternative Synonym:
Brepocitinib, Inhibitor, Janus kinase, inhibit, JAK1, JAK2, JAK3, JAK, PF-06700841, PF06700841, PF 06700841, Tyk2, Tyrosine Kinases, TyrosineKinases
Produktbeschreibung
Brepocitinib (PF-06700841) is a selective small molecule inhibitor with high potency for JAK1 and TYK2 kinases, and moderate activity against JAK2. It is widely used in preclinical research to investigate JAK/STAT signaling pathways in autoimmune and inflammatory disease models, both in vitro and in vivo.
Produkteigenschaften
Molekulargewicht:
389.4
Reinheit:
99.82% (May vary between batches)
CAS Nummer:
[1883299-62-4]
Formel:
C18H21F2N7O
Target-Kategorie:
Tyrosine Kinases,JAK
Anwendungsbeschreibung
Anwendungsbeschreibung:
Solubility: H2O:Insoluble,DMSO:75 mg/mL (192.6 mM),Ethanol:75 mg/mL (192.6 mM)
